surmount-1 tirzepatide weight loss nondiabetic SURMOUNT-1: Adults achieve of 16% or more at 72 weeks with surmount-1 trial tirzepatide weight loss

Who you choose is important, so ensure that your values and cultures align

This can help individuals eat less, leading to an average weight loss of 15% when combined with diet and exercise

A randomized controlled trial is a type of study where participants are randomly assigned to different treatments, which provides stronger scientific evidence

Swelling of face, lips, tongue, or throat

Instead, we want to help your body make enough GLP-1s on its own by setting up the right conditions

So lets break it down in therapist language: what it is, what the science actually supports, and why this is going to land in your treatment room more often next year